BCL3 has also been suggested to be a key determinant in the COX-2-mediated response to inflammatory cytokines in colorectal tumour cells, promoting PGE2-driven tumorigenesis [59] – a pathway known to be involved in several hallmarks of cancer and associated with WNT signaling [60]. This evidence concerns the gene BCL3 and cancer.